Orchestra BioMed
Latest round
- Series D
Last raised
- Jun 2022
Total raised
- $144M
Investors
- 6
About Orchestra BioMed
Orchestra BioMed, Inc.Founded in 2017, Orchestra BioMed, Inc. is based in New Hope, US. The company specializes in creating advanced medical solutions. The company has executed 8 deals since its inception.Orchestra BioMed specializes in the development of innovative therapeutic product candidates that target significant unmet medical needs in the treatment of hypertension and atherosclerotic artery disease. Their core offerings include BackBeat CNT™, an investigational bioelectronic treatment designed to provide immediate and sustained reductions in blood pressure while modulating the autonomic nervous system. Additionally, the company is advancing Virtue SAB, a novel drug/device combination that delivers an extended-release formulation of sirolimus during balloon angioplasty procedures, eliminating the need for balloon coating or permanent implants.Orchestra BioMed's revenue model is primarily based on strategic partnerships with leading medical device companies, enabling the commercialization of their innovative products. The company engages in risk-reward sharing arrangements that align their interests with those of their partners, facilitating the development and distribution of their flagship products, BackBeat CNT™ and Virtue SAB. Transactions typically involve collaborative agreements that may include milestone payments, royalties on sales, and shared clinical development costs.Orchestra BioMed, Inc. plans to expand its product offerings and geographic reach. Future products are currently under design with a focus on enhancing therapeutic options for hypertension and arterial diseases.00 mn, which will support further product development and market entry initiatives.
Who invested in Orchestra BioMed
6 investors across 3 rounds
See all investors in Orchestra BioMed
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Orchestra BioMed
Who invested in Orchestra BioMed?
Orchestra BioMed has 6 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Orchestra BioMed raised?
Orchestra BioMed has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Orchestra BioMed last raise money?
Orchestra BioMed's most recent round on record is a Series D, in Jun 2022.
What does Orchestra BioMed do?
Orchestra BioMed is a biotechnology company.
Where is Orchestra BioMed headquartered?
Orchestra BioMed is headquartered in New Hope, US.
Which VCs invest in companies like Orchestra BioMed?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Orchestra BioMed's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series D
Raising like Orchestra BioMed? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.